文献速递妇科

肥胖子宫内膜癌患者腹腔镜与机器人子宫切除术:转开腹与并发症的系统综述与Meta分析

Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications.
PubMed 文献 · Am J Obstet Gynecol · 2019-05-10

本系统综述纳入51项观察性研究、10800例肥胖(BMI≥30 kg/m2)子宫内膜癌患者,比较腹腔镜与机器人子宫切除术的转开腹率及围手术期并发症。腹腔镜与机器人子宫切除术转开腹率在BMI≥30 kg/m2患者中分别为6.5%与5.5%,在BMI≥40 kg/m2患者中分别为7.0%与3.8%;器官/血管损伤、静脉血栓栓塞和输血率均低且两组间无明显差异。现有文献受选择偏倚和混杂偏倚限制,需要随机试验来指导该人群的实践标准。

要点

  • 肥胖子宫内膜癌患者腹腔镜与机器人子宫切除术的围手术期并发症率相似。
  • 机器人子宫切除术可能减少病态肥胖患者因体位不耐受导致的转开腹。
  • 现有文献受选择偏倚和混杂偏倚限制,需要随机试验指导实践标准。

核心结论

  • 在肥胖子宫内膜癌患者中,机器人子宫切除术与腹腔镜子宫切除术的围手术期并发症率相似,但机器人子宫切除术可能减少病态肥胖患者因体位不耐受导致的转开腹。
  • 现有文献受选择偏倚和混杂偏倚限制,需要随机试验来指导该人群的实践标准。

研究设计与样本

  • 系统综述与Meta分析,系统检索MEDLINE、EMBASE和Evidence-Based Medicine Reviews(2000年1月1日至2018年7月18日)。
  • 纳入51项观察性研究,共10800例肥胖(BMI≥30 kg/m2)子宫内膜癌患者,研究水平BMI为31.0-56.3 kg/m2。
  • 采用Institute of Health Economics Quality Appraisal Checklist评估单臂研究偏倚风险,采用Newcastle-Ottawa Quality Scale评估双臂研究偏倚风险。

主要发现

  • BMI≥30 kg/m2患者中,腹腔镜与机器人子宫切除术的转开腹合并比例分别为6.5%(95%CI 4.3-9.9)与5.5%(95%CI 3.3-9.1)。
  • BMI≥40 kg/m2患者中,腹腔镜与机器人子宫切除术的转开腹合并比例分别为7.0%(95%CI 3.2-14.5)与3.8%(95%CI 1.4-9.9)。
  • 因粘连/内脏肥胖导致暴露不充分是两种术式转开腹最常见原因,腹腔镜为32%,机器人子宫切除术为61%;而Trendelenburg体位不耐受导致腹腔镜转开腹31%、机器人子宫切除术转开腹6%。
  • 器官/血管损伤合并比例:腹腔镜3.5%(95%CI 2.2-5.5),机器人子宫切除术1.2%(95%CI 0.4-3.4);静脉血栓栓塞:腹腔镜0.5%(95%CI 0.2-1.2),机器人子宫切除术0.5%(95%CI 0.1-2.0);输血:腹腔镜2.8%(95%CI 1.5-5.1),机器人子宫切除术2.1%(95%CI 1.6-3.8);均低且两组间无明显差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 现有文献受选择偏倚和混杂偏倚限制。
  • 需要随机试验来指导该人群的实践标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE DATA: Robotic assistance may facilitate completion of minimally invasive hysterectomy, which is the standard of care for the treatment of early-stage endometrial cancer, in patients for whom conventional laparoscopy is challenging. The aim of this systematic review was to assess conversion to laparotomy and perioperative complications after laparoscopic and robotic hysterectomy in patients with endometrial cancer and obesity (body mass index, ≥30 kg/m2). STUDY: We systematically searched MEDLINE, EMBASE, and Evidence-Based Medicine Reviews (January 1, 2000, to July 18, 2018) for studies of patients with endometrial cancer and obesity (body mass index, ≥30 kg/m2) who underwent primary hysterectomy. STUDY APPRAISAL AND SYNTHESIS METHODS: We determined the pooled proportions of conversion, organ/vessel injury, venous thromboembolism, and blood transfusion. We assessed risk of bias with the Institute of Health Economics Quality Appraisal Checklist for single-arm studies, and Newcastle-Ottawa Quality Scale for double-arm studies. RESULTS: We identified 51 observational studies that reported on 10,800 patients with endometrial cancer and obesity (study-level body mass index, 31.0-56.3 kg/m2). The pooled proportions of conversion from laparoscopic and robotic hysterectomy were 6.5% (95% confidence interval, 4.3-9.9) and 5.5% (95% confidence interval, 3.3-9.1), respectively, among patients with a body mass index of ≥30 kg/m2, and 7.0% (95% confidence interval, 3.2-14.5) and 3.8% (95% confidence interval, 1.4-9.9) among patients with body mass index of ≥40 kg/m2. Inadequate exposure because of adhesions/visceral adiposity was the most common reason for conversion for both laparoscopic (32%) and robotic hysterectomy (61%); however, intolerance of the Trendelenburg position caused 31% of laparoscopic conversions and 6% of robotic hysterectomy conversions. The pooled proportions of organ/vessel injury (laparoscopic, 3.5% [95% confidence interval, 2.2-5.5]; robotic hysterectomy, 1.2% [95% confidence interval, 0.4-3.4]), venous thromboembolism (laparoscopic, 0.5% [95% confidence interval, 0.2-1.2]; robotic hysterectomy, 0.5% [95% confidence interval, 0.1-2.0]), and blood transfusion (laparoscopic, 2.8% [95% confidence interval, 1.5-5.1]; robotic hysterectomy, 2.1% [95% confidence interval, 1.6-3.8]) were low and not appreciably different between arms. CONCLUSION: Robotic and laparoscopic hysterectomy have similar rates perioperative complications in patients with endometrial cancer and obesity, but robotic hysterectomy may reduce conversions because of positional intolerance in patients with morbid obesity. Existing literature is limited by selection and confounding bias, and randomized trials are needed to inform practice standards in this population.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cusimano MC, Simpson AN, Dossa F, et al. Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications. Am J Obstet Gynecol. 2019. PMID: 31082383. doi:10.1016/j.ajog.2019.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。